[The present, something from the past and the future of therapy of type II diabetes (NIDDM). II].
Insulin resistance which is the typical sign of NIDDM and the metabolic "X" syndrome is the basic problem of successful treatment of NIDDM. The author discusses therapeutic possibilities--biguanides, some new perspective pharmaceutical preparations and possibilities of combined treatment with PAD and insulin. Although it is not quite clear so far which treatment is the best, prevention of late diabetic complications, intensive NIDDM treatment must be focused on perfect control of the blood sugar level as well as on correction of associated metabolic abnormalities, as much as possible.